Research map: The elusive link: EBV in MS

Back to the article

Papers in this map

  1. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis · Kjetil Bjørnevik · 2022 · 2083 citations · Cited by this paper
  2. The role of immunosenescence and chronic medical conditions on the immune response to respiratory syncytial virus in older individuals · 2026 · Related
  3. Vitamin effects on the immune system: vitamins A and D take centre stage · J. Rodrigo Mora · 2008 · 1571 citations · Cited by this paper
  4. Harnessing the immune system in lung cancer: emerging role of the microbiome · 2026 · Related
  5. Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation · Sheng Chen · 2007 · 1125 citations · Cited by this paper
  6. Organ damage in systemic sclerosis: linking immune activation, vasculopathy, and fibrosis to precision treatment · 2026 · Related
  7. Vitamin D intake and incidence of multiple sclerosis · Kassandra L. Munger · 2004 · 1099 citations · Cited by this paper
  8. Beyond the binary: understanding inflammatory bowel disease in the context of HIV-induced immunodeficiency · 2026 · Related
  9. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM · Tobias Volker Lanz · 2022 · 898 citations · Cited by this paper
  10. Inflammatory bowel disease and primary sclerosing cholangitis: immunological links and clinical outlook · 2026 · Related
  11. Expansion of a unique CD57 + NKG2C hi natural killer cell subset during acute human cytomegalovirus infection · Sandra López‐Vergès · 2011 · 827 citations · Cited by this paper
  12. Keratoconus: an ocular manifestation of systemic immune dysregulation? · 2026 · Related
  13. Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis · Jerold J. M. Chun · 2010 · 808 citations · Cited by this paper
  14. Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis · 2026 · Related
  15. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain · Barbara Serafini · 2007 · 769 citations · Cited by this paper
  16. Reconsidering the interpretation of polyautoimmunity in chronic immune-mediated neuropathies: association, misclassification, and clinical implications · 2026 · Related
  17. Multiple sclerosis · Dejan Jakimovski · 2023 · 598 citations · Cited by this paper
  18. Malignancies in the context of Inborn errors of immunity: an immunologist’s view · 2026 · Related
  19. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. · Jacques M. Lemire · 1984 · 508 citations · Cited by this paper
  20. Sarcoid-like reactions: a comprehensive review of granulomatous diseases mimicking sarcoidosis · 2026 · Related
  21. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). · WF Rigby · 1984 · 469 citations · Cited by this paper
  22. Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis · Mark Gorman · 2009 · 456 citations · Cited by this paper
  23. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria · Xavier Montalbán · 2025 · 430 citations · Cited by this paper
  24. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells · Alan B. Rickinson · 1987 · 376 citations · Cited by this paper
  25. Human Herpesviruses · 2007 · 375 citations · Cited by this paper
  26. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis · Amit Bar‐Or · 2014 · 366 citations · Cited by this paper
  27. Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection · Naeem Ahmad Khan · 2004 · 353 citations · Cited by this paper
  28. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis · Jorge R. Oksenberg · 2008 · 350 citations · Cited by this paper
  29. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. · Jacques M. Lemire · 1985 · 341 citations · Cited by this paper
  30. Association between clinical disease activity and Epstein–Barr virus reactivation in MS · K.-P. Wandinger · 2000 · 304 citations · Cited by this paper
  31. B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies · Maria Teresa Cencioni · 2021 · 272 citations · Cited by this paper
  32. Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010 · Jennifer B. Dowd · 2013 · 264 citations · Cited by this paper
  33. Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis · Jan D. Lünemann · 2009 · 231 citations · Cited by this paper
  34. Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond · Tobias Ruck · 2015 · 213 citations · Cited by this paper
  35. Difference in Disease Burden and Activity in Pediatric Patients on Brain Magnetic Resonance Imaging at Time of Multiple Sclerosis Onset vs Adults · Emmanuelle L. Waubant · 2009 · 202 citations · Cited by this paper
  36. The immune response to primary EBV infection: a role for natural killer cells · Hilary J Williams · 2005 · 196 citations · Cited by this paper
  37. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis · Hannes Vietzen · 2023 · 179 citations · Cited by this paper
  38. Multiple Sclerosis and Regulatory T Cells · Cristina Maria Costantino · 2008 · 164 citations · Cited by this paper
  39. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells · Asma Hassani · 2018 · 164 citations · Cited by this paper

Source: OpenAlex (CC0)